Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Clinics in Laboratory Medicine|November 26, 2008
Pharmacogenomics: the key to improved drug therapy in transplant patientsGilbert J Burckart
Expert Opinion on Investigational Drugs|July 25, 2006
Ciclosporin aerosol in lung transplantationGilbert J Burckart
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|October 12, 2020
The Revolution in Pediatric Drug Development and Drug Use: Therapeutic Orphans No MoreGilbert J Burckart, Clara Kim
Pharmacogenomics|February 9, 2010
Update on the clinical pharmacogenomics of organ transplantationGilbert J Burckart, Shashi Amur
Therapeutic Drug Monitoring|January 19, 2006
Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?Gilbert J Burckart, Xiaomei I Liu
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|January 31, 2019
Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal UseEdit Muhari-Stark, Gilbert J Burckart
The AAPS Journal|March 26, 2026
Effect of Incentivizing Pediatric Studies on the Development of Pediatric-Friendly FormulationsSusan M Abdel-Rahman, Gilbert J Burckart
Clinical Pharmacology and Therapeutics|February 1, 2018
Pediatric Drug Development: Outlook for Science-Based InnovationDionna J Green, Issam Zineh, Gilbert J Burckart
Clinical Pharmacology and Therapeutics|October 11, 2022
Fine-Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of ComplexityRosane Charlab, Gilbert J Burckart, Gregory H Reaman
Journal of Clinical Pharmacology|June 29, 2021
Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020Francis G Green, Kyunghun Park, Gilbert J Burckart
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Clinics in Laboratory Medicine|November 26, 2008
Pharmacogenomics: the key to improved drug therapy in transplant patientsGilbert J Burckart
Expert Opinion on Investigational Drugs|July 25, 2006
Ciclosporin aerosol in lung transplantationGilbert J Burckart
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|October 12, 2020
The Revolution in Pediatric Drug Development and Drug Use: Therapeutic Orphans No MoreGilbert J Burckart, Clara Kim
Pharmacogenomics|February 9, 2010
Update on the clinical pharmacogenomics of organ transplantationGilbert J Burckart, Shashi Amur
Therapeutic Drug Monitoring|January 19, 2006
Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?Gilbert J Burckart, Xiaomei I Liu
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|January 31, 2019
Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal UseEdit Muhari-Stark, Gilbert J Burckart
The AAPS Journal|March 26, 2026
Effect of Incentivizing Pediatric Studies on the Development of Pediatric-Friendly FormulationsSusan M Abdel-Rahman, Gilbert J Burckart
Clinical Pharmacology and Therapeutics|February 1, 2018
Pediatric Drug Development: Outlook for Science-Based InnovationDionna J Green, Issam Zineh, Gilbert J Burckart
Clinical Pharmacology and Therapeutics|October 11, 2022
Fine-Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of ComplexityRosane Charlab, Gilbert J Burckart, Gregory H Reaman
Journal of Clinical Pharmacology|June 29, 2021
Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020Francis G Green, Kyunghun Park, Gilbert J Burckart
Pageof 13